Navigation Links
Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP)
Date:4/20/2009

"We love Scent To Sleep products so much, we bought the company"

MILWAUKEE, April 20 /PRNewswire/ -- Innovative Custom Products, Inc. (ICP) announced today that ICP has acquired Scent To Sleep - a California company. Scent To Sleep manufactures and distributes a revolutionary All Natural Non-Drowsy Sleep Mist (www.ScentToSleep.com).

According to Sherry Williams, Senior VP, "We love Scent To Sleep products so much, we bought the company. Scent To Sleep is so easy to use and really gets the job done. By simply applying 3 to 5 sprays on your pillow, bed, pajamas, or in the bedroom five minutes before bedtime, you will feel relaxed, and go right to sleep...and the best part is you wake up feeling refreshed and energized."

Scent To Sleep is all natural, safe, environmentally friendly, and one of the most innovative non-prescription sleep aids to hit the market. Its proprietary formulation contains no chemicals or harmful ingredients, has no horrible prescription side effects, and you never have to take a pill.

According to Sherry, consumers love this product too! "With one exposure in Woman's World Magazine, sales increased ten-fold." Scent To Sleep is expected in some retail chains later this year. In the meantime, consumers can purchase Scent To Sleep at www.drmistICP.com, the corporation's ecommerce website. Scent To Sleep is available in Luscious Lavender Scent and Decadent Green Apple with Vanilla, backed by the company's 100% Money-Back Guarantee, and retails for $11.99.

The company is currently offering a 2-for-1 National TV Promotional Special as a way to introduce Scent To Sleep to the public. Simply visit www.drmistICP.com and order Scent To Sleep and a second bottle will be shipped FREE with your order.

Retailers who would like to offer Scent To Sleep to their customers can contact the company at contact@icpCorporation.com or at (414) 358-1802 or visit the company's corporate websites at www.icpCorporation.com or www.drmistICP.com.

More information is also available at www.ScentToSleep.com

About Innovative Custom Products, Inc.

Innovative Custom Products, Inc. (ICP) is a Wisconsin corporation, in business since 1992, a manufacturer and distributor of consumer health and OTC pharmaceutical products. Innovative Custom Products, Inc. (ICP) is the owner of www.drmistICP.com and www.ScentToSleep.com. To contact Investor Relations, email contact@icpCorporation.com or telephone (414) 358-1802 or visit: www.icpCorporation.com

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Innovative Custom Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. University HealthSystem Consortium Names Ascent Healthcare Solutions Supplier of the Year at UHC 2009 Performance Excellence Forum
2. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
3. CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents
4. Gaining new insights into mentoring programs for adolescent girls
5. Naturally fluorescent molecules may serve as cancer biomarker
6. Task Force Recommends Screening Adolescents for Clinical Depression
7. Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents
8. Study finds most adolescents sent to group homes still involved with drugs/crime seven years later
9. Society for Adolescent Medicine Meeting to Focus on E-Teens and How Adolescents Incorporate Technology and Health
10. Reducing suicidal behaviors among adolescents
11. New Research Released at Annual Society for Adolescent Medicine Meeting Provides Vital Insights into Adolescent Health Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... York, NY (PRWEB) , ... March 24, 2017 ... ... global scale; from third world countries to hospitals in the United States, it’s ... a conversation on the current obstacles facing infection prevention and offers strategies for ...
(Date:3/24/2017)... , ... March 24, 2017 , ... The iaedp Foundation, ... other medical professionals caring for those suffering from the full spectrum of disordered eating, ... as eating disorders professionals from nearly all 50 states and several countries converged on ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, ... their training and leads programs. , In February, 2017, Empower Brokerage introduced their ... Performance Partners is designed to teach how to maximize their sales efforts, as ...
(Date:3/24/2017)... ... , ... “The Communion of Saints: A Pastor’s Potpourri of ... across the United States. “The Communion of Saints” is the creation of ... congregations in seven states throughout his long career of devotion to the church. ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... 24, 2017 FinancialBuzz.com News Commentary  ... According to ... cannabis market research, the legal cannabis market is projected to ... despite conflicting signals from the current presidential administration. The report ... two biggest drivers of growth in this industry are the ...
(Date:3/24/2017)... Research and Markets has announced the addition of ... to their offering. ... IPF pipeline is very strong with a total of 97 drug candidates. ... and Sanofi are involved in the development of the IPF therapeutics. The ... Phase III stage, 15 are in Phase II stage, 12 are in ...
Breaking Medicine Technology: